Education & Human Capital Global On demand · 24-48h

Global Gait Training Robots Market Strategic Research Report

Global Gait Training Robots Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Gait Training Robots Market
$1.29B2025
19%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Exoskeleton Type, End-Effector Type

By Application: Rehabilitation Centers, Long-Term Care Facilities, Home Care Settings, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Ekso Bionics (USA), ReWalk Robotics (USA), Hocoma (Switzerland), Cyberdyne (Japan), Fourier Intelligence (China), Guangzhou Yikang Medical (China), Bionic Yantra (India), Tyromotion (Austria), Reha Technology (Switzerland), AlterG (USA), Rex Bionics (New Zealand), Aretech (USA), Motek Medical (Netherlands), MediTouch (Israel), BAMA Teknoloji (Turkey), Wandercraft (France)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 143 pages
Market size 2025
$1.29B
Billion USD
Forecast CAGR
19%
2025-2032
Forecast 2032
$4.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Gait Training Robots market size is predicted to grow from US$ 1,291 million in 2025 to US$ 4,336 million in 2032; it is expected to grow at a CAGR of 19.0% from 2026 to 2032.

In 2025, global Gait Training Robot output reached about 120,000 units and global capacity of around 160,000 units. The average price is about USD 11,000 per unit, with gross margins near 37%. Gait Training Robots are robotic rehabilitation systems designed to assist patients in relearning walking patterns after neurological or musculoskeletal impairments (such as stroke, spinal cord injury, or Parkinson’s disease) by providing repetitive, controlled, and sensor-guided lower-limb movement through exoskeletons or end-effector devices; their supply chain starts upstream with key components such as actuators (electric motors, hydraulics), sensors (force, motion, EMG), control systems (embedded processors, AI algorithms), structural materials (aluminum alloys, carbon fiber), and software platforms, supplied by companies in robotics, semiconductor, and advanced materials industries; the midstream involves system integration and manufacturing by specialized medical robotics companies that design complete gait rehabilitation systems, perform clinical validation, and ensure regulatory compliance (e.g., FDA, CE); downstream includes distribution to hospitals, rehabilitation centers, research institutes, and elderly care facilities, supported by service providers offering installation, training, maintenance, and data analytics, with end users being patients undergoing physical rehabilitation under supervision of healthcare professionals.

Global key Gait Training Robots players cover Ekso Bionics (USA), ReWalk Robotics (USA), Hocoma (Switzerland), Cyberdyne (Japan), Fourier Intelligence (China), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gait Training Robots market?

What factors are driving Gait Training Robots market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gait Training Robots market opportunities vary by end market size?

How does Gait Training Robots break out by Type, by Application?

This report presents a comprehensive overview of the global Gait Training Robots market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Exoskeleton Type
  • End-Effector Type

Segment by Body-Weight Support Ratio

  • High Support (>50%)
  • Medium Support (20–50%)
  • Low Support (<20%)

Segment by Application

  • Rehabilitation Centers
  • Long-Term Care Facilities
  • Home Care Settings
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Gait Training Robots market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Rehabilitation Centers, Long-Term Care Facilities, Home Care Settings evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Gait Training Robots Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 19%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.29B
2025
Forecast
$4.4B
2032
CAGR
19%
2025–2032
Régions
5
global
Key companies
Ekso Bionics (USA)ReWalk Robotics (USA)Hocoma (Switzerland)Cyberdyne (Japan)Fourier Intelligence (China)Guangzhou Yikang Medical (China)Bionic Yantra (India)Tyromotion (Austria)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Exoskeleton TypeEnd-Effector Type
By Application
Rehabilitation CentersLong-Term Care FacilitiesHome Care SettingsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Exoskeleton Type
  • 3.1.3 End-Effector Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Rehabilitation Centers
  • 4.1.3 Long-Term Care Facilities
  • 4.1.4 Home Care Settings
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Ekso Bionics (USA)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 ReWalk Robotics (USA)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Hocoma (Switzerland)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cyberdyne (Japan)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Fourier Intelligence (China)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Guangzhou Yikang Medical (China)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Bionic Yantra (India)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tyromotion (Austria)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Reha Technology (Switzerland)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AlterG (USA)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Rex Bionics (New Zealand)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Aretech (USA)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Motek Medical (Netherlands)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 MediTouch (Israel)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 BAMA Teknoloji (Turkey)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Wandercraft (France)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Gait Training Robots market?
The global Gait Training Robots market is estimated at US$ 1.29 billion in 2025 (base year) and is projected to reach US$ 4.34 billion by 2032.
What is the forecast CAGR for the Gait Training Robots market?
The market is expected to grow at a CAGR of 19.0% from 2026 to 2032, expanding from US$ 1.29 billion in 2025 to US$ 4.34 billion in 2032, roughly 3.4 times its base-year value.
What is Gait Training Robots?
In 2025, global Gait Training Robot output reached about 120,000 units and global capacity of around 160,000 units. The average price is about USD 11,000 per unit, with gross margins near 37%.
How is the Gait Training Robots market segmented by type?
By type, the market is segmented into Exoskeleton Type and End-Effector Type.
What are the key applications of Gait Training Robots?
Key applications covered include Rehabilitation Centers, Long-Term Care Facilities, Home Care Settings and Others.
Which companies are profiled in the Gait Training Robots market report?
Key players profiled include Ekso Bionics (USA), ReWalk Robotics (USA), Hocoma (Switzerland), Cyberdyne (Japan), Fourier Intelligence (China), Guangzhou Yikang Medical (China), Bionic Yantra (India) and Tyromotion (Austria), among 16 companies covered in total.
What geographies does the Gait Training Robots market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Gait Training Robots?
What factors are driving Gait Training Robots market growth, globally and by region?
Who should buy the Gait Training Robots market report?
The report is intended for manufacturers and solution providers, distributors and end users in Rehabilitation Centers, Long-Term Care Facilities and Home Care Settings, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Gait Training Robots market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.